Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled date : 2022 - 03 - 08 save search
J&J Faces Scrutiny over Revelation of Involvement in Controversial Experiment
Published: 2022-03-08 (Crawled : 18:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
ces
OccamzRazor announces closing of $6.1M financing round to launch their AI-enabled discovery pipeline and advance preclinical development in Parkinson's.
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
parkinson preclinical pre-clinical
Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa
Published: 2022-03-08 (Crawled : 17:00) - aspenpharma.com
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
covid-19 covid vaccine africa
TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases
Published: 2022-03-08 (Crawled : 14:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
treatment disease trex media
Electrophysiology Ablation Market reflects a CAGR of around 8.4% over the forecast period (2021-2031)
Published: 2022-03-08 (Crawled : 13:30) - prnewswire.com
MDT | News | $78.7 -0.48% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
BSX | $67.96 1.3M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
ABT | News | $105.52 -0.36% 1.6M
|
Health Technology
|
| O: -2.16%
H: 0.94%
C: -1.53%
ATRC | $23.57 0.51% 76K
|
Health Technology
|
| O: -2.88%
H: 2.17%
C: 0.69%
Teon Therapeutics Names Serge Messerlian as CEO
Published: 2022-03-08 (Crawled : 12:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
ceo therapeutics
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-08 (Crawled : 11:00) - prnewswire.com
GNMSF | $281.02 210
|
Health Technology
|
| O: -0.14%
H: 5.36%
C: 5.36%
TAK | $13.215 0.49% 210K
|
Health Technology
|
| O: -2.75%
H: 0.28%
C: -1.04%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
GSK | $39.44 -0.4% 560K
|
Health Technology
|
| O: 0.38%
H: 1.81%
C: 0.28%
BMY | $48.145 0.64% 2.5M
|
Health Technology
|
| O: -1.55%
H: 0.71%
C: -0.28%
ABBV | $167.2 1.8% 1.3M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
GILD | $65.99 -1.4% 1.9M
|
Health Technology
|
| O: 1.4%
H: 0.7%
C: -1.15%
GMAB | $28.6 0.25% 77K
|
Health Technology
|
| O: -0.3%
H: 3.38%
C: 0.32%
AMGN | $265.48 0.53% 360K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
ema drug report
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | $0.7995 99.88% 73M
|
Finance
BPTH | $6.21 91.67% 58M
|
Health Technology
INVO | $1.36 78.95% 3.6M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
VTNR S | $1.295 32.25% 5.5M
|
Industrial Services
ALRN | $5.53 30.12% 250K
|
Health Technology
HOLO | $2.86 27.68% 28M
|
XPON | $2.43 25.91% 7.2M
|
Your saved searches
Save your searches and get alerts when important news are released.